
Dacmed 500mg Injection
Salt Composition: Dacarbazine
Expiry Date: 01/2028
Inclusive of all taxes
1 Injection
About The Product
Skin Cancer
Dacmed 500mg Injection is a chemotherapy-based anticancer medicine. This medicine is primarily used to treat patients diagnosed with metastatic malignant melanoma, a type of skin cancer, soft tissue sarcoma, and Hodgkin lymphoma (cancer that forms in the lymph system). The active ingredient of Dacmed is Dacarbazine, which belongs to the drug class of alkylating agents. It is administered as an injection by an experienced nurse or medical professional.
Side Effects
- Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely.
- In that case, the patient should contact the doctor immediately.
- Some common side effects of Carfilnat 60mg Injection include: Nausea Vomiting Hair loss Headache Skin reactions Loss of appetite Vision problems Low levels of RBC, WBC, and platelets Some Serious side effects are: Sore throat Liver problems Allergic reaction Extreme tiredness Numbness of the face Fits, confusion, & lethargy Severe vomiting or diarrhea Contact your doctor immediately if you experience any severe or unusual side effects.
How To Use
- Dacmed 500mg Injection is given intravenously by a doctor or trained nurse under strict medical supervision.
- It is not self-administrable.
- The dosage and duration of the treatment are determined by the doctor based on the stage & type of cancer and the patient's health condition.
How It Works
Dacmed 500mg Injection is an alkylating agent that works by alkylation. It inhibits DNA synthesis, which disturbs the normal functioning of DNA.
This process arrests the growth and proliferation of cancer cells, eventually leading to their death.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Dacmed 500mg Injection.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
It is advised to use effective birth control methods and avoid pregnancy during the treatment with Dacmed 500mg Injection.
A person should avoid smoking while undergoing treatment with Dacmed Injection. Smoking may reduce the effectiveness of medicine.
Monitor your blood sugar & pressure, Kidney & Liver function (KFT & LFT), Heart function at proper intervals after taking Dacmed 500mg.
Swelling of hands, lips, and weight gain are some of the side effects observed after taking this injection. To reduce them, the doctor may suggest some medication.
Skin becomes supersensitive after taking Dacmed 500mg Injection. It is advised to cover your skin exposed to direct sun rays and use high SPF sunscreen before going out.
It is advised to avoid taking analgesics/ antacids (medicines used to neutralize the stomach acid) while taking Dacmed Injection, as it may reduce the effectiveness of the medicine.
Keep your body hydrated as Diarrhea is one of the common side effects experienced after taking Dacmed 500mg. Consult your doctor if it doesn't stop or if blood appears in your stools.
FAQs
It is important to store the Dacmed 500mg Injection away from light during both storage and administration.
Exposure to light can cause it to become unstable and reduce its effectiveness.
Reference
1. Keilholz, U., Punt, C.
J., Gore, M., Kruit, W., Patel, P., Lienard, D., ... & Eggermont, A. M.
(2005). Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.
Journal of clinical oncology, 23(27), 6747-6755. 2.
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., ... & Wolchok, J. D.
(2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
New England Journal of Medicine, 364(26), 2517-2526. 3.
Serrone, L., Zeuli, M., Sega, F. M., & Cognetti, F.
(2000). Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Journal of experimental & clinical cancer research: CR, 19(1), 21-34. 4.
Ugurel, S., Paschen, A., & Becker, J. C.
(2013). Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent.
Journal of Investigative Dermatology, 133(2), 289-292. 5.
Cocconi, G., Bella, M., Calabresi, F., Tonato, M., Canaletti, R., Boni, C., ... & Bacchi, M. (1992).
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. New England Journal of Medicine, 327(8), 516-523.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
